| 1. | | Recruiting | 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors
Condition: Cancer |
| 2. | | Not yet recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer |
| 3. | | Not yet recruiting | 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer |
| 4. | | Recruiting | Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer |
| 5. | | Not yet recruiting | Adjuvant Chemoradiotherapy Using Cisplatin and Docetaxel After Complete Resection in Treating Patients With Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ... |
| 6. | | Recruiting | Adjuvant Erlotinib After Completing Chemoradiotherapy in Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Condition: Head and Neck Cancer |
| 7. | | Recruiting | Adjuvant Intraperitoneal Carboplatin With Paclitaxel in Treating Patients Who Had Initial Debulking Surgery for Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer |
| 8. | | Recruiting | Administration of EBV-Specific Cytotoxic T-Lymphocytes to Patients with EBV-Positive Cancer of the Nose and Throat
Conditions: Nasopharyngeal Cancer; Epstein-Barr Virus Infections |
| 9. | | Recruiting | Assessing the Results of Lip Surgery in Patients With Cleft Lip and Palate
Conditions: Cleft Lip; Cleft Palate |
| 10. | | Recruiting | Benzydamine in Treating Radiation-Induced Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, and/or Nasopharynx
Conditions: lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer |
| 11. | | Recruiting | Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Condition: Head and Neck Cancer |
| 12. | | Recruiting | Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer |
| 13. | | Recruiting | Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
Condition: Head and Neck Cancer |
| 14. | | Recruiting | Biological Specifications for Denture Designs
Condition: Tooth Loss |
| 15. | | Recruiting | Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases
Conditions: Endocrine Cancer; Gastrointestinal Cancer; Head and Neck Cancer; metastatic cancer |
| 16. | | Recruiting | Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck
Conditions: lip and oral cavity cancer; Salivary Gland Cancer |
| 17. | | Recruiting | Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 18. | | Recruiting | Bradykinin Receptors and Pain
Condition: Tooth, Impacted |
| 19. | | Recruiting | Brief Treatment for Temporomandibular Pain
Conditions: Temporomandibular Joint Syndrome; Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint; Orofacial Pain |
| 20. | | Recruiting | Capecitabine Combined with Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Breast Cancer; Gastrointestinal Cancer; Head and Neck Cancer; thorax and respiratory cancer; unclassified and other cancer |
| 21. | | Recruiting | Carboplatin Plus Docetaxel and Paclitaxel in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
Conditions: Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer |
| 22. | | Recruiting | Carboplatin With or Without Liposomal Doxorubicin in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: peritoneal cavity cancer; recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer |
| 23. | | Recruiting | Caries Transmission Prevention in Alaska Native Infants
Condition: Dental Caries |
| 24. | | Not yet recruiting | Celecoxib and/or EKB-569 in Preventing Oral Cancer in Patients With Oral Leukoplakia
Conditions: lip and oral cavity cancer; Salivary Gland Cancer; Precancerous Condition |
| 25. | | Recruiting | Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia
Condition: Head and Neck Cancer |
| 26. | | Recruiting | Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
Conditions: Head and Neck Cancer; thorax and respiratory cancer |
| 27. | | Recruiting | Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 28. | | Not yet recruiting | Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Head and Neck Cancer
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ... |
| 29. | | Recruiting | Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; metastatic squamous neck cancer with occult primary; Nasopharyngeal Cancer; ... |
| 30. | | Recruiting | Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer |
| 31. | | Recruiting | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
Condition: Cancer |
| 32. | | Recruiting | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Central Nervous System Cancer
Conditions: adult brain tumor; paranasal sinus and nasal cavity cancer; primary central nervous system lymphoma |
| 33. | | Recruiting | Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer
Conditions: stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer |
| 34. | | Recruiting | Chemotherapy With or Without Gene Therapy in Treating Patients With Unresectable Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer |
| 35. | | Recruiting | Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer |
| 36. | | Recruiting | Cisplatin or Carboplatin Combined With Gemcitabine in Treating Patients With Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor
Conditions: high-grade salivary gland carcinoma; low-grade salivary gland carcinoma; Salivary Gland Cancer |
| 37. | | Recruiting | Combination Chemotherapy and Surgery in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer |
| 38. | | Recruiting | Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
Conditions: bone marrow ablation; Cancer |
| 39. | | Recruiting | Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Conditions: Nose Cancers; Oral Cancer; Throat Cancer |
| 40. | | Recruiting | Combination Chemotherapy in Treating Women With Stage III Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: stage III ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer |
| 41. | | Recruiting | Combination Chemotherapy Plus Erlotinib in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer |
| 42. | | Recruiting | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Condition: Cancer |
| 43. | | Recruiting | Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
Conditions: Fallopian Tube Cancer; peritoneal cavity cancer; recurrent ovarian epithelial cancer |
| 44. | | Recruiting | Comparison of Combination Chemotherapy Regimens in Treating Newly Diagnosed Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Conditions: stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; ... |
| 45. | | Recruiting | Comparison of Gene Therapy With Chemotherapy in Treating Patients With Head and Neck Cancer
Condition: Head and Neck Cancer |
| 46. | | Recruiting | Comparison of Psychological and Pharmacological Treatments for Pain due to TMD
Condition: Temporomandibular Joint Disorders |
| 47. | | Recruiting | Complementary Medicine Approaches to TMD Pain Management
Condition: Temporomandibular Joint Disorders |
| 48. | | Recruiting | Concomitant Radiation and Cisplatin with and without Tirapazamine in Treatment of Advanced Head and Neck Cancer
Condition: Head and Neck Neoplasms |
| 49. | | Recruiting | Cytochlor and Tetrahydrouridine as Radiosensitizers Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat)
Conditions: stage III squamous cell carcinoma of the lip and oral cavity; stage III squamous cell carcinoma of the oropharynx; ... |
| 50. | | Recruiting | Diagnosis and Evaluation of Patients Needing Third Molar (Wisdom Tooth) Extraction and Patients with Chronic Facial Pain
Conditions: Facial Pain; Temporomandibular Joint Disorder |
